Osimertinib resistance in non-small cell lung cancer: Pathways and potential solutions
1 Mga view
administrator
07/14/23
Li et al. “Toward the next generation EGFR inhibitors: an overview of osimertinib resistance mediated by EGFR mutations in non-small cell lung cancer.” Cell Communication and Signaling (2023)
Read the article: https://doi.org/10.1186/s12964-023-01082-8
Video produced by http://www.researchersquare.com/researchers/videos
Magpakita ng higit pa
Mga Komento sa Facebook
Walang nakitang komento